Cardiovascular damage in Alzheimer disease: Autopsy findings from the bryan ADRC

Journal of Biomedicine and Biotechnology

Volumn 2005, Issue 2, 2005, Pages 189-197

  Corder, Elizabeth H ^a   Ervin, John F ^b   Lockhart, Evelyn ^b   Szymanski, Mari H ^b   Schmechel, Donald E ^b   Hulette, Christine M ^b,c  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BODY MASS; BRAIN PERFUSION; CANCER DIAGNOSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEMENTIA; FEMALE; GASTROINTESTINAL INFECTION; GENOTYPE; HEART MUSCLE; HEART VALVE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; ONSET AGE; ORGAN WEIGHT; PATHOGENESIS; RESPIRATORY TRACT INFECTION; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS; URINARY TRACT INFECTION;

EID: 27744469124     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/JBB.2005.189     Document Type: Article

References (46)

1. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262(18):2551-2556.
2. Silver MH, Jilinskaia E, Peris TT. Cognitive functional status of age-confirmed centenarians in a population-based study. J Gerontol B Psychol Sci Soc Sci. 2001;56(3):P134-P140.
3. Seshadri S, Wolf PA, Beiser A, et al. Lifetime risk of dementia and Alzheimer's disease The impact of mortality on risk estimates in the Framingham study. Neurology. 1997;49(6):1498-1504.
4. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Nat Acad Sci USA. 1993;90(5):1977-1981.
5. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43(8):1467-1472.
6. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921-923.
7. Lucotte G, Visvikis S, Leininger-Muler B, et al. Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease. Am J Med Genet. 1994;54(3):286-288.
8. Lucotte G, Aouizerate A, Gerard N, Turpin JC, Landais P. Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease. Am J Med Genet. 1995;60(6):566-569.
9. Lucotte G, Turpin JC, Landais P. Apolipoprotein E-epsilon 4 allele doses in late-onset Alzheimer's disease. Ann Neurol. 1994;36(4):681-682.
10. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Nat Acad Sci USA. 1993;90(20):9649-9653.
11. Cumming AM, Robertson FW. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease. Clin Genet. 1984;25(4):310-313.
12. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8(1):1-21.
13. Laakso M, Kesaniemi A, Kervinen K, Jauhiainen M, Pyorala K. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes. BMJ. 1991;303(6811):1159-1162.
14. van Bockxmeer FM, Mamotte CD. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet. 1992;340(8824):879-880.
15. Eichner JE, Kuller LH, Orchard TJ, et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 1993;71(2):160-165.
16. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation. 1995;91(2):265-269.
17. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 1991;49(2):338-349.
18. Wilson PW. Established risk factors and coronary artery disease: the Framingham study. Am J Hypertens. 1994;7(pt2):7S-12S.
19. Gerdes LU, Gerdes C, Kervinen K, et al. The apolipoprotein epsilon 4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study. Circulation. 2000;101(12):1366-1371.
20. Slooter AJ, Tang MX, van Duijn CM, et al. Apolipoprotein E epsilon 4 and the risk of dementia with stroke. A population-based investigation. JAMA. 1997;277(10):818-821.
21. Goldstein LB, Vitek MP, Dawson H, Bullman S. Expression of the apolipoprotein E gene does not affect motor recovery after sensorimotor cortex injury in the mouse. Neuroscience. 2000;99(4):705-710.
22. Pasquier F, Henon H, Leys D. Risk factors and mechanisms of post-stroke dementia. Rev Neurol (Paris). 1999;155(9):749-753.
23. Ervin JF, Pannell C, Szymanski M, Welsh-Bohmer K, Schmechel DE, Hulette CM. Vascular smooth muscle actin is reduced in Alzheimer disease brain: a quantitative analysis. J Neuropathol Exp Neurol. 2004;63(7):735-741.
24. Corder EH, Basun H, Fratiglioni L, et al. Inherited frailty. ApoE alleles determine survival after a diagnosis of heart disease or stroke at ages 85+. Ann N Y Acad Sci. 2000;908:295-298.
25. Schachter F, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6(1):29-32.
26. Aronson MK, Ooi WL, Morgenstern H, et al. Women, myocardial infarction, and dementia in the very old. Neurology. 1990;40(7):1102-1106.
27. Breteler MM, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. BMJ. 1994;308(6944):1604-1608.
28. Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC 3rd. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci. 1995;131(2):162-169.
29. Prince M, Cullen M, Mann A. Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial. Neurology. 1994;44(1):97-104.
30. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia aging study. JAMA. 1995;274(23):1846-1851.
31. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347(9009):1141-1145.
32. Guo Z, Viitanen M, Winblad B, Fratiglioni L. Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition. J Am Geriatr Soc. 1999;47(6):723-726.
33. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 1997;349(9046):151-154.
34. Lass P, Buscombe JR, Harber M, Davenport A, Hilson AJ. Cognitive impairment in patients with renal failure is associated with multiple-infarct dementia. Clin Nucl Med. 1999;24(8):561-565.
35. Irina A, Seppo H, Arto M, Paavo R Sr, Hilkka S. β-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients. Stroke. 1999;30:613-618.
36. Hulette CM, Welsh-Bohmer KA, Crain B, Szymanski MH, Sinclaire NO, Roses AD. Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience. Arch Pathol Lab Med. 1997;121(6):615-618.
37. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology. 1990;40(6):887-890.
38. Centers for Disease Control. Agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus. MMWR. 1988;37:S5.
39. Manton KG, Woodbury MA, Tolley HD. Statistical Applications Using Fuzzy Sets. New York, NY:John Wiley & Sons; 1994.
40. Manton KG, Stallard E, Corder LS. The dynamics of dimensions of age-related disability 1982 to 1994 in the US elderly population. J Gerontol A Biol Sci Med Sci. 1998;53(1):B59-B70.
41. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Proc 2nd International Symposium on Information Theory. Budapest, Hungary:Akademiai Kiado; 1973:267-281.
42. Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol. 1998;57(12):1168-1174.
43. Kosunen O, Talasniemi S, Lehtovirta M, et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke. 1995;26(5):743-748.
44. Meyer JS, Rauch G, Rauch RA, Haque A. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol Aging. 2000;21(2):161-169.
45. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341(3):142-147.
46. Stengard JH, Pekkanen J, Sulkava R, Ehnholm C, Erkinjuntti T, Nissinen A. Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men. Acta Neurol Scand. 1995;92(4):297-298.